全人工心脏支持后心脏移植的初期与长期结果
本研究回顾性分析1988至2019年间73例植入SynCardia临时全人工心脏的患者,其中50例(68%)后续接受心脏移植。移植后院内死亡率为10%,5年、10年和12年生存率分别为79.1%、76.5%和72.4%,与同期直接心脏移植相似。移植时机在人工心脏植入后3-6个月似可获得最佳生存。
要点
- 全人工心脏桥接移植后长期生存率与直接移植相似。
- 移植后院内死亡率为10%,需警惕严重心包反应。
- 人工心脏植入后3-6个月行移植可能生存最佳。
核心结论
- SynCardia临时全人工心脏作为严重双心室衰竭患者的桥接移植,长期结果令人鼓舞。
- 全人工心脏后心脏移植技术具有挑战性,尤其是严重心包反应时,术前应识别潜在陷阱。
研究设计与样本
- 回顾性分析前瞻性收集的数据,单中心1988至2019年连续73例植入SynCardia临时全人工心脏的患者。
- 其中50例(68%)后续接受心脏移植并纳入分析。
主要发现
- 心脏移植后院内死亡率为10%(n=5)。
- 重症监护室中位停留33天(范围5-278),住院中位时间41天(范围28-650)。
- 21例(42%)在移植术中因严重心包反应行部分或全部心包切除术。
- 移植后5年、10年、12年生存率分别为79.1±5.9%(n=32)、76.5±6.3%(n=22)、72.4±7.1%(n=12),与同期686例无全人工心脏的直接心脏移植长期生存相似。
- 全人工心脏植入后3-6个月内行心脏移植似乎提供最佳生存(P=0.007)。
临床怎么用
- 对于严重双心室衰竭患者,可考虑使用SynCardia临时全人工心脏作为桥接移植。
- 移植术前应评估心包反应情况,以便术中处理。
- 移植时机可考虑在人工心脏植入后3-6个月。
局限性
- 回顾性研究,单中心经验。
- 样本量有限(50例接受移植)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: At our centre, the SynCardia temporary Total Artificial Heart (TAH-t) (SynCardia Systems, LLC, Tucson, AZ, USA) is used to provide long-term support for patients with biventricular failure as a bridge to a transplant. However, a heart transplant (HT) after such support remains challenging. The aim of this retrospective study was to assess the immediate and long-term results following an HT in the cohort of patients who had a TAH-t implant. METHODS: A total of 73 patients were implanted with the TAH-t between 1988 and 2019 in our centre. Of these 73 consecutive patients, 50 (68%) received an HT and are included in this retrospective analysis of prospectively collected data. RESULTS: In the selected cohort, in-hospital mortality after an HT was 10% (n = 5). The median intensive care unit stay was 33 days (range 5-278). The median hospital stay was 41 days (range 28-650). A partial or total pericardiectomy was performed during the HT procedure in 21 patients (42%) due to a severe pericardial reaction. Long-term survival rates after an HT at 5, 10 and 12 years were 79.1 ± 5.9% (n = 32), 76.5 ± 6.3% (n = 22) and 72.4 ± 7.1% (n = 12), respectively, which was similar to the long-term survival for a primary HT without TAH-t during the same period (n = 686). An HT performed within 3-6 months post-TAH-t implantation appeared to provide the best survival (P = 0.007). Eight (16%) patients required chronic dialysis during the subsequent follow-up period, with 3 patients requiring a kidney transplant. CONCLUSIONS: The long-term outcomes with the SynCardia TAH-t as a bridge to transplant in patients with severe biventricular failure are very encouraging. Our review noted that an HT following TAH-t can be technically challenging, especially in the case of a severe pericardial reaction, with potential pitfalls that should be recognized preoperatively.
引用
- David CH, Lacoste P, Nanjaiah P, et al. A heart transplant after total artificial heart support: initial and long-term results. Eur J Cardiothorac Surg. 2020. PMID: 32830239. doi:10.1093/ejcts/ezaa261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。